PoliticsPolicy change

A year ago, President Trump pledged to lower Medicaid drug prices. Has that happened?

Published 1w ago · Updated 1w ago

AI summary41s readPositive

All fifty states have finally joined the federal Medicaid drug pricing model, overcoming earlier doubts about state participation.

The Trump administration has announced that all fifty states have agreed to participate in a new Medicaid drug pricing model aimed at lowering costs. This development follows initial uncertainty over which medications would be affected and whether individual states would opt in after the program was first pledged. The national rollout marks a significant step forward for the federal pricing initiative after months of questions surrounding state compliance.

Every state in the nation has now chosen to join the administration's drug pricing framework.
Earlier uncertainty surrounded which specific pharmaceutical products would be targeted by the reductions.
State participation was previously voluntary, requiring individual jurisdictions to opt in before implementation.

By the numbers

50states joining the pricing model

Timeline

Sep 17Questions lingered regarding which drugs would be affected and whether states would choose to opt into the pricing changes.
Sep 18The administration actively promoted the program designed to reduce Medicaid prescription drug costs.
Sep 19Officials announced that all fifty states have officially joined the Medicaid drug pricing framework.

Why it matters

Efforts to control soaring prescription costs are central to federal healthcare policy debates, directly impacting state budgets and millions of vulnerable beneficiaries relying on public assistance programs.

What outlets agree on

The administration initiated a push to lower Medicaid drug prices, and all fifty states have ultimately joined the pricing model.

Tune your feed

Reactions

In this story

TrumpMedicaid

Covered by 3 outlets

67% of the sources are Left

67%33%

Lean ratings via Ad Fontes Media

Are you a publisher? Tell us how we may use your content